Berliner Boersenzeitung - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.087691
AFN 77.216219
ALL 99.146863
AMD 431.530556
ANG 2.008679
AOA 1031.493152
ARS 1071.444832
AUD 1.636718
AWG 2.00463
AZN 1.833968
BAM 1.951391
BBD 2.250335
BDT 133.190246
BGN 1.959446
BHD 0.419383
BIF 3230.238279
BMD 1.11291
BND 1.439161
BOB 7.701667
BRL 6.030747
BSD 1.114592
BTN 93.214008
BWP 14.663221
BYN 3.647491
BYR 21813.042196
BZD 2.246534
CAD 1.51141
CDF 3194.052731
CHF 0.943726
CLF 0.037557
CLP 1036.308283
CNY 7.866943
CNH 7.873957
COP 4649.605752
CRC 577.330644
CUC 1.11291
CUP 29.492123
CVE 110.016412
CZK 25.100356
DJF 198.449303
DKK 7.459502
DOP 66.909416
DZD 147.515328
EGP 54.01173
ERN 16.693655
ETB 128.268622
FJD 2.449794
FKP 0.847547
GBP 0.839886
GEL 2.985379
GGP 0.847547
GHS 17.554492
GIP 0.847547
GMD 76.791162
GNF 9630.326265
GTQ 8.61561
GYD 233.107099
HKD 8.674791
HNL 27.647777
HRK 7.566689
HTG 146.879437
HUF 394.157231
IDR 16915.513413
ILS 4.200674
IMP 0.847547
INR 93.082762
IQD 1460.014134
IRR 46859.088964
ISK 152.513253
JEP 0.847547
JMD 175.104342
JOD 0.788716
JPY 159.072742
KES 143.776286
KGS 93.790539
KHR 4523.940499
KMF 492.46545
KPW 1001.618654
KRW 1481.155606
KWD 0.339471
KYD 0.928697
KZT 533.744026
LAK 24610.612066
LBP 99807.176845
LKR 339.266457
LRD 222.881353
LSL 19.418996
LTL 3.286135
LVL 0.673189
LYD 5.309004
MAD 10.808577
MDL 19.446874
MGA 5021.6758
MKD 61.47802
MMK 3614.689295
MNT 3781.669204
MOP 8.946281
MRU 44.118708
MUR 51.049094
MVR 17.083347
MWK 1932.41655
MXN 21.523736
MYR 4.68484
MZN 71.113011
NAD 19.418996
NGN 1825.529362
NIO 41.012723
NOK 11.696776
NPR 149.160304
NZD 1.785843
OMR 0.428437
PAB 1.114592
PEN 4.184283
PGK 4.425001
PHP 61.979083
PKR 309.981864
PLN 4.27323
PYG 8700.419088
QAR 4.063319
RON 4.974488
RSD 117.080389
RUB 103.309148
RWF 1500.840195
SAR 4.176335
SBD 9.260263
SCR 15.165156
SDG 669.441157
SEK 11.332482
SGD 1.439622
SHP 0.847547
SLE 25.426999
SLL 23337.167151
SOS 636.966462
SRD 33.223683
STD 23034.996587
SVC 9.751965
SYP 2796.220485
SZL 19.401981
THB 36.94413
TJS 11.846103
TMT 3.906315
TND 3.375772
TOP 2.615116
TRY 37.881682
TTD 7.575033
TWD 35.593074
TZS 3032.057276
UAH 46.18624
UGX 4138.685594
USD 1.11291
UYU 45.786543
UZS 14199.044041
VEF 4031576.086267
VES 40.879734
VND 27355.33557
VUV 132.126949
WST 3.113325
XAF 654.50164
XAG 0.036076
XAU 0.000431
XCD 3.007696
XDR 0.826041
XOF 654.47817
XPF 119.331742
YER 278.617301
ZAR 19.454062
ZMK 10017.526769
ZMW 29.005331
ZWL 358.356668
  • RBGPF

    3.5000

    60.5

    +5.79%

  • CMSC

    -0.0350

    25.02

    -0.14%

  • RYCEF

    0.3800

    6.93

    +5.48%

  • CMSD

    0.0930

    25.073

    +0.37%

  • VOD

    -0.1750

    10.055

    -1.74%

  • GSK

    -0.4150

    42.015

    -0.99%

  • SCS

    -0.9600

    13.15

    -7.3%

  • NGG

    -1.2400

    68.81

    -1.8%

  • RIO

    2.3700

    65.28

    +3.63%

  • BCC

    5.8600

    142.92

    +4.1%

  • RELX

    0.6750

    48.045

    +1.4%

  • BCE

    -0.1300

    35.48

    -0.37%

  • JRI

    -0.0400

    13.4

    -0.3%

  • BTI

    -0.2450

    37.635

    -0.65%

  • AZN

    0.6300

    79.21

    +0.8%

  • BP

    0.6650

    33.095

    +2.01%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

(S.G.Stein--BBZ)